News

Published on 19 Feb 2025 on GuruFocus.com · via Yahoo Finance

Halozyme Therapeutics Inc (HALO) Q4 2024 Earnings Call Highlights: Record...


Article preview image

Release Date: February 18, 2025 For the complete transcript of the earnings call, please refer to...

NASDAQ.HALO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Halozyme shares surge 6% on strong Q4 results, upbeat 2025 outlook By...

Halozyme shares surge 6% on strong Q4 results, upbeat 2025 outlook

Investing.com 19 Feb 2025

Halozyme Therapeutics Inc (HALO) Q4 2024 Earnings Call Highlights: Record...

Release Date: February 18, 2025 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 19 Feb 2025

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

However, the growth potential is expected to have been partially offset by lower Kuvan sales. BMR...

Zacks · via Yahoo Finance 17 Feb 2025

Halozyme Therapeutics, Inc. (HALO): A Cheap Biotech Stock to Invest In Now

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we ...

Insider Monkey · via Yahoo Finance 12 Feb 2025

Are Options Traders Betting on a Big Move in Halozyme (HALO) Stock?

Investors in Halozyme Therapeutics, Inc. HALO need to pay close attention to the stock based on...

Zacks · via Yahoo Finance 9 Jan 2025

HALO Raises 2025 Financial Guidance, Keeps 2024 View, Stock Up

Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its...

Zacks · via Yahoo Finance 9 Jan 2025

Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics...

LDOS, Amazon.com, Inc. AMZN, Halozyme Therapeutics, Inc. HALO and BioMarin Pharmaceutical Inc. BM...

Zacks · via Yahoo Finance 7 Jan 2025

HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up

Halozyme Therapeutics, Inc. HALO announced that it has withdrawn its non-binding proposal to acqu...

Zacks · via Yahoo Finance 25 Nov 2024

Halozyme Withdraws Bid to Purchase Drug Developer Evotec

Have a confidential tip for our reporters? Halozyme Therapeutics Inc. withdrew its bid to purchas...

Bloomberg 22 Nov 2024

Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook

Halozyme Therapeutics, Inc. (NASDAQ:HALO) saw its shares rise on Friday after the company announc...

Benzinga · via Yahoo Finance 22 Nov 2024